TLDR
- Bitcoin surged approximately 5% to reach $71,418, boosting cryptocurrency-related equities such as Strategy (+8%), Coinbase (+7%), and Riot Platforms (+4%)
- Moderna resolved a $950M patent conflict concerning its COVID-19 vaccine, representing a smaller hit than market participants anticipated
- Ross Stores exceeded Q4 projections and increased forward guidance, pushing shares higher by as much as 7.5%
- GitLab tumbled approximately 9% even after surpassing Q4 estimates, following disappointing annual revenue projections
- Horizon Technology Finance declined 10% as total investment income of $20.7M fell short of the $23.9M forecast
Bitcoin experienced a robust recovery during Wednesday’s session, advancing roughly 5% to settle near $71,418. This upward momentum created a ripple effect throughout cryptocurrency-linked equities.
Strategy posted an 8% advance, Coinbase climbed approximately 7%, while MARA Holdings similarly increased 7%. Riot Platforms, Robinhood Markets, Galaxy Digital, and Hut 8 each registered gains ranging from 4% to 5%. Circle Internet Group contributed with a 6% rise.
The cryptocurrency sector’s resurgence followed a recent downturn connected to escalating geopolitical tensions in the Middle East. Market participants appeared to rotate back into higher-risk securities as broader market conditions showed signs of stabilization.
Precious metals miners also experienced upward movement Wednesday. Newmont advanced 2.8% while Freeport-McMoRan increased 1.9%, benefiting from geopolitical uncertainty that drove certain investors toward traditional safe-haven instruments like gold.
Moderna Resolves Patent Dispute for $950M
Moderna finalized a $950 million settlement agreement with Arbutus Biopharma and Genevant Sciences. The litigation centered on intellectual property disputes related to its COVID-19 and RSV vaccine products.
Investors welcomed the settlement as considerably smaller than feared. Moderna’s COVID-19 vaccine franchise has produced between $45 billion and $50 billion in total sales.
The settlement amount becomes payable in Q3 and will appear as a first-quarter expense. Following this payment, Moderna projects finishing the year with cash reserves between $4.5 billion and $5 billion.
Moderna plans to continue its appeal with the U.S. Federal Circuit. A positive outcome could eliminate any further financial obligation, though an unfavorable verdict might necessitate an additional payment of up to $1.3 billion within a 90-day window.
Ross Stores delivered impressive performance, climbing as high as 7.5% during premarket hours. The discount retailer surpassed Q4 profit expectations and provided first-quarter guidance substantially exceeding Wall Street projections.
For the current quarter, Ross anticipates comparable store sales growth between 7% and 8%, significantly outpacing analyst forecasts of roughly 3.7%. Management also authorized a 10% dividend increase.
GitLab and Horizon Slide on Weak Outlooks
GitLab declined between 8.5% and 9% notwithstanding stronger-than-expected Q4 results. The software company’s full-year revenue outlook of $1.099 billion to $1.118 billion disappointed investors expecting $1.13 billion.
CEO Bill Staples acknowledged dissatisfaction with the revenue projection and presented a five-point strategy designed to accelerate growth momentum.
Horizon Technology Finance retreated 10% following disclosure of total investment income reaching $20.7 million, undershooting the $23.9 million analyst estimate. The company’s net asset value per share also experienced a modest quarterly decline.
CrowdStrike advanced 1.1% after delivering Q4 earnings and revenue figures that exceeded expectations. Box surged 6.2% following results that topped Wall Street forecasts along with encouraging current-quarter guidance.
Broadcom traded 1% higher in anticipation of its fiscal first-quarter earnings announcement scheduled for after market close, with analysts projecting a 51% year-over-year increase in semiconductor revenue.





